0001209191-23-018013.txt : 20230310 0001209191-23-018013.hdr.sgml : 20230310 20230310195136 ACCESSION NUMBER: 0001209191-23-018013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230309 FILED AS OF DATE: 20230310 DATE AS OF CHANGE: 20230310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Detheux Michel CENTRAL INDEX KEY: 0001816196 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39401 FILM NUMBER: 23725339 MAIL ADDRESS: STREET 1: C/O ITEOS THERAPEUTICS, INC. STREET 2: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iTeos Therapeutics, Inc. CENTRAL INDEX KEY: 0001808865 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 ARSENAL STREET STREET 2: BLDG 312, FLOOR 3, SUITE 301 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 857-204-4583 MAIL ADDRESS: STREET 1: 321 ARSENAL STREET STREET 2: BLDG 312, FLOOR 3, SUITE 301 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-09 0 0001808865 iTeos Therapeutics, Inc. ITOS 0001816196 Detheux Michel 321 ARSENAL STREET WATERTOWN MA 02472 0 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 16.66 2023-03-09 4 A 0 346000 0.00 A 2033-03-09 Common Stock 346000 346000 D Stock Option (Right to Buy) 16.66 2023-03-09 4 G 0 254997 0.00 D 2033-03-09 Common Stock 254997 91003 D Stock Option (Right to Buy) 16.66 2023-03-09 4 G 0 254997 0.00 A 2033-03-09 Common Stock 254997 254997 I By MG3A This stock option shall vest over four years, with 25% vesting on March 9, 2024 and thereafter in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the Issuer. The reporting person transferred these stock options to MG3A, a Belgian partnership of which the reporting person is the manager and the reporting person's spouse is the successor manager. /s/ Adi Osovsky, as Attorney-in-Fact 2023-03-10